Potential cytochrome P-450 drug–drug interactions in adults with metastatic solid tumors and effect on eligibility for Phase I clinical trials-Reference-Cited by-同舟云学术

Potential cytochrome P-450 drug–drug interactions in adults with metastatic solid tumors and effect on eligibility for Phase I clinical trials

Published:2015-06-01 Issue:11 Volume:72 Page:958-965
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Wisinski Kari B.¹,Cantu Colby A.²,Eickhoff Jens³,Osterby Kurt⁴,Tevaarwerk Amye J.⁵,Heideman Jennifer⁶,Liu Glenn⁷,Wilding George⁸,Johnston Susan⁹,Kolesar Jill M.¹⁰

Affiliation:

1. School of Medicine and Public Health, University of Wisconsin (UW), Madison, and Assistant Professor, UW Carbone Cancer Center, Madison

2. School of Medicine and Public Health, UW

3. Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, UW

4. UW Hospital and Clinics, Madison

5. School of Medicine and Public Health, UW, and Assistant Professor, UW Carbone Cancer Center

6. School of Medicine and Public Health, UW, and Program Manager, UW Carbone Cancer Center

7. School of Medicine and Public Health, UW, and UW Carbone Cancer Center

8. School of Medicine and Public Health, UW, and Professor, UW Carbone Cancer Center

9. UW Carbone Cancer Center, and UW Hospital and Clinics

10. School of Pharmacy, UW, and Faculty Supervisor, Analytical Laboratory for Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics, UW Carbone Cancer Center

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/72/11/958/28451388/ajhp0958.pdf

Reference24 articles.

1. Gu Q Dillon CF Burt V . Prescription drug use continues to increase: US prescription drug data for 2007–2008 (September 2010). www.cdc.gov/nchs/data/databriefs/db42.htm (accessed 2014 Oct 14).

2. Prescription drug use, diagnoses, and healthcare utilization among the elderly;Jorgensen;Ann Pharmacother,2001

3. Comorbidity and polypharmacy in elderly cancer patients: the significance on treatment outcome and tolerance;Jørgensen;J Geriatr Oncol,2010

4. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States;Qato;JAMA,2008

5. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes;Gnjidic;J Clin Epidemiol,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical care in the screening process of phase I oncohaematological clinical trials;European Journal of Hospital Pharmacy;2024-08-13

2. Navigating the challenges of clinical trial professionals in the healthcare sector;Frontiers in Medicine;2024-06-03

3. Impact of Medication Reconciliation in Oncology Early Phase Studies: A Drug-Drug Interaction Retrospective Study;JCO Oncology Practice;2023-11-09

4. Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study;European Journal of Clinical Pharmacology;2022-10-21

5. Intérêt des activités de pharmacie clinique au sein d’un centre d’essais cliniques de phase précoce en cancérologie et satisfaction des participants;Le Pharmacien Hospitalier et Clinicien;2021-09